Bellerophon Therapeutics, Inc. Operating Lease, Expense
Bellerophon Therapeutics, Inc. reported Operating Lease, Expense of $700.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-03-31
- Bellerophon Therapeutics, Inc. operating lease, expense for fiscal 2022 was $700.00K, a 0.00% change from fiscal 2021.
- Bellerophon Therapeutics, Inc. operating lease, expense for fiscal 2021 was $700.00K, a 0.00% change from fiscal 2020.
- Bellerophon Therapeutics, Inc. operating lease, expense for fiscal 2020 was $700.00K, a 16.67% increase from fiscal 2019.
- Bellerophon Therapeutics, Inc. operating lease, expense for fiscal 2019 was $600.00K.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2022-12-31 | $700.00K 10-K · filed 2023-03-31 |
| 2021-12-31 | $700.00K 10-K · filed 2023-03-31 |
| 2020-12-31 | $700.00K 10-K · filed 2022-03-31 |
| 2019-12-31 | $600.00K 10-K · filed 2021-03-11 |